An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
about
NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cellsThe Epstein-Barr virus nuclear protein 2 acidic domain forms a complex with a novel cellular coactivator that can interact with TFIIEA role for SKIP in EBNA2 activation of CBF1-repressed promotersEpstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.Viruses associated with human cancerEBNA2 and activated Notch induce expression of BATFP-TEFb goes viralStructural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIHProtein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.BS69/ZMYND11 C-Terminal Domains Bind and Inhibit EBNA2.Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptovirusesNotch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.EBNA-LP associates with cellular proteins including DNA-PK and HA95.Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-associationHydrophobic cluster analysis predicts an amino-terminal domain of varicella-zoster virus open reading frame 10 required for transcriptional activation.The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy.C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.The EBNA2 polyproline region is dispensable for Epstein-Barr virus-mediated immortalization maintenanceThe Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoterComplete genomic sequence of an Epstein-Barr virus-related herpesvirus naturally infecting a new world primate: a defining point in the evolution of oncogenic lymphocryptoviruses.EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.Modulation of enhancer looping and differential gene targeting by Epstein-Barr virus transcription factors directs cellular reprogramming.Epstein-Barr virus nuclear protein 3C binds to the N-terminal (NTD) and beta trefoil domains (BTD) of RBP/CSL; only the NTD interaction is essential for lymphoblastoid cell growth.The Epstein-Barr virus BamHI C promoter is not essential for B cell immortalization in vitro, but it greatly enhances B cell growth transformation.The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.The EBNA-2 N-Terminal Transactivation Domain Folds into a Dimeric Structure Required for Target Gene Activation.Direct interactions between Epstein-Barr virus leader protein LP and the EBNA2 acidic domain underlie coordinate transcriptional regulation.Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia.Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.The Epstein-Barr virus nuclear protein 2 acidic domain can interact with TFIIB, TAF40, and RPA70 but not with TATA-binding protein.Contribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJkEpstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappaHsp72 up-regulates Epstein-Barr virus EBNALP coactivation with EBNA2Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas.Molecular genetic analysis of Epstein-Barr virus Cp promoter functionEpstein-Barr virus latent membrane protein 2 associates with and is a substrate for mitogen-activated protein kinase.Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activationThe Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.
P2860
Q22254088-2EA88929-DC6E-4ECE-ADB1-CCD22A7DE1DFQ24329182-FC73AF69-2F78-4FE9-8DF3-398BD8B3555EQ24524363-74CAEC7B-C9D9-4462-8F2B-632B5DD32EFCQ24540313-27BDFA20-9485-46F8-B619-B3DD753FD349Q24653900-B0B2533B-A681-423C-8F43-31E88DA4B5CAQ24679432-773F9737-F93B-47A1-AC7E-DC3F8838C4D0Q26741360-7F763180-0909-418E-B312-96071282A64DQ27682610-0D06CAE5-752F-42FE-AEB8-FE416754B27DQ28114910-E4D13D13-D49D-45A4-B4F5-7621FFD99399Q30981859-D7BC55E3-5F0B-49ED-872A-1CF4C60B86D0Q33786088-BC87CB20-F09B-45EF-B08D-D2A3044B36B3Q33787090-A38ACBB2-68E2-484C-8E37-1D8F7D3F4EB9Q33795078-CD41F726-586B-463E-B547-36AC17ADABA3Q33842309-8AF43B40-9D22-4715-ADAD-C2B8A273664DQ33850943-5D7D4D75-79FF-47AA-893B-12995B2F154AQ33850964-06413A64-DEE1-4DD0-90DC-DC0A5D216376Q33900854-B2190E45-00A2-4480-8A68-683CC07648DAQ33918592-ED2B3EBF-9BDA-4E0B-B67D-D1FC9AE23180Q33998709-6BA1FBF1-F25D-4557-907F-05F0EBED4EBEQ34341875-29CA6908-9CE3-40A1-A2D3-1D3C6BD2F293Q34355226-51C7202E-6F63-4E3D-843F-546B1F12C265Q34360303-35A69DAF-BF85-44AF-A5CC-836A3A56639DQ34977875-0831C2FB-FD99-4AE2-A6A7-1463C8641F90Q34998243-768563AF-A440-42CF-8AC3-B032C8EDB259Q35014692-5DFD1E9D-A89C-49DA-9802-92472D406DB5Q35076676-008D8780-32F7-4EA7-99DF-0525BC74888CQ35648541-54FEC929-ADA9-4041-87A2-CAE415C23A61Q35664999-56C39CFD-857C-4816-AF36-6E62E264DAABQ35732134-BDB0F2A6-417F-4845-AA82-E0C7CF289A11Q35798133-58DADFF7-DBAE-474F-B266-0DE61B390474Q35829475-59F48D78-0CFB-44DB-8F84-A8F87FB61D77Q35830605-61663523-0260-4670-9AA5-27FE53079021Q35835726-D8BF343C-88E0-41D1-934C-0C417B964D6BQ35839108-66257843-68B0-4814-A836-1F6657B1D9A1Q35839875-6E6C704A-452F-4F20-8058-BB5BA2B74A9AQ35854314-9A9A0DAB-F4D6-4110-B1B0-A468EAA2F669Q35856784-06927AC8-7DC4-41F5-A454-A3515804FC11Q35887119-D4CECA84-97AD-49D6-86E1-9BC264D741BDQ35891360-D0A07A70-E94D-472B-9356-9F194A14D15CQ36581891-0DE6899B-983F-4A0A-BE15-856FC41A5073
P2860
An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
An Epstein-Barr virus nuclear ...... ect transcriptional activator.
@en
type
label
An Epstein-Barr virus nuclear ...... ect transcriptional activator.
@en
prefLabel
An Epstein-Barr virus nuclear ...... ect transcriptional activator.
@en
P2860
P1433
P1476
An Epstein-Barr virus nuclear ...... ect transcriptional activator.
@en
P2093
P2860
P304
P407
P577
1991-11-01T00:00:00Z